J&J’s Icotyde will take on AbbVie’s blockbuster injectable Skyrizi as analysts forecast a blockbuster future for the pill.
Novartis has signed an agreement to acquire SNV4818, a pan-mutant selective Phosphoinositide 3-kinase alpha (PI3Kα) inhibitor ...
An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and ...
The FDA has issued a CRL to Aldeyra Therapeutics for its new drug application (NDA) of reproxalap to treat dry eye disease.
R1 Therapeutics has raised $77.5m in an oversubscribed Series A funding to advance AP306 for hyperphosphatemia in CKD ...
GSK's RSV jab, Arexvy will now compete for market share with Pfizer’s Abrysvo and Moderna’s mRESVIA across the high-risk ...
The court ruling reverses several changes by the CDC’s vaccine panel to childhood immunisation recommendations.
In a recent article, Sanofi presented preclinical data for an in vivo CAR-T platform that reengineers T cells directly within ...
While the FDA can legally make prescription drugs OTC, legal expert Heidi Gertner notes that this wider shift depends on ...
Sentynl Therapeutics has signed an agreement with PRG S&T to license Progerinin, an investigational molecule intended to ...
Bavarian Nordic has signed a manufacturing agreement with SII, expanding its strategic partnership through a contract for its ...
PRISM BioLab has collaborated with Receptor.AI to integrate AI and physics-guided technologies in the discovery of orally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results